These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3031897)

  • 21. Genotype-dependent behavioral sensitivity to mu vs. kappa opiate agonists. I. Acute and chronic effects on mouse locomotor activity.
    Gwynn GJ; Domino EF
    J Pharmacol Exp Ther; 1984 Nov; 231(2):306-11. PubMed ID: 6092613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice.
    Ribeiro Do Couto B; Aguilar MA; Manzanedo C; Rodríguez-Arias M; Miñarro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1035-43. PubMed ID: 15380865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of narcotics and narcotic antagonists on operant behavior.
    McMillan DE
    Adv Biochem Psychopharmacol; 1973; 8(0):345-59. PubMed ID: 4604406
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of fosB in behaviours related to morphine reward and spatial memory.
    Solecki W; Krowka T; Kubik J; Kaczmarek L; Przewlocki R
    Behav Brain Res; 2008 Jul; 190(2):212-7. PubMed ID: 18407360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
    Colpaert FC; Janssen PA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):193-9. PubMed ID: 6747824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
    Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of GABA(B) receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats.
    Zarrindast MR; Massoudi R; Sepehri H; Rezayof A
    Physiol Behav; 2006 Jan; 87(1):31-8. PubMed ID: 16274709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphine-nicotine interaction in conditioned place preference in mice after chronic nicotine exposure.
    Vihavainen T; Piltonen M; Tuominen RK; Korpi ER; Ahtee L
    Eur J Pharmacol; 2008 Jun; 587(1-3):169-74. PubMed ID: 18466896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Morphine antagonists (pentazocine, nalorphine, naloxone and buprenophine)].
    Fournier T; Besserve P; Lefèvre P; Lephay A; Ossart M
    Cah Anesthesiol; 1988 May; 36(3):223-34. PubMed ID: 2840178
    [No Abstract]   [Full Text] [Related]  

  • 30. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.
    Shippenberg TS; Bals-Kubik R; Herz A
    J Pharmacol Exp Ther; 1993 Apr; 265(1):53-9. PubMed ID: 8386244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modulation of circadian rhythms of aggressive behavior and locomotor activity by opiate receptor agonists and antagonists in mice].
    Kubynin AN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1988; 38(1):172-3. PubMed ID: 2837021
    [No Abstract]   [Full Text] [Related]  

  • 32. Stimulus properties of opioids with mixed agonist and antagonist activity.
    Holtzman SG
    Fed Proc; 1982 May; 41(7):2328-32. PubMed ID: 6281084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1985 Jul; 234(1):81-9. PubMed ID: 4009506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors.
    Noble F; Cox BM
    Brain Res; 1996 Apr; 716(1-2):107-17. PubMed ID: 8738226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihistaminic-opioid combination: effect on locomotor activity in mice.
    Sansone M
    Pol J Pharmacol Pharm; 1988; 40(5):515-23. PubMed ID: 3253717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential antagonism by naltrexone of the effects of opioids on a fixed-ratio discrimination in rats.
    Moerschbaecher JM; Devia C; Brocklehurst C
    J Pharmacol Exp Ther; 1988 Jan; 244(1):237-46. PubMed ID: 3336001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of pentazocine and other opiates on shock detection in the rat: involvement of opiate and dopamine receptors.
    Hernández LL; Appel JB
    Psychopharmacology (Berl); 1980 Feb; 67(2):155-63. PubMed ID: 6245423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral effects of opioid subtypes compared with benzodiazepines in the staircase paradigm.
    Milman A; Weizman R; Rigai T; Rice KC; Pick CG
    Behav Brain Res; 2006 Jun; 170(1):141-7. PubMed ID: 16574254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide and nonpeptide ligands for opioid receptors.
    Misicka A
    Acta Pol Pharm; 1995; 52(5):349-63. PubMed ID: 8960271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.